167 related articles for article (PubMed ID: 34011306)
21. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
23. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
24. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
[TBL] [Abstract][Full Text] [Related]
25. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
[TBL] [Abstract][Full Text] [Related]
26. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
[No Abstract] [Full Text] [Related]
27. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
[TBL] [Abstract][Full Text] [Related]
29. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
[TBL] [Abstract][Full Text] [Related]
30. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
31. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
32. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
33. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
34. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
Muñoz-Largacha JA; Gower AC; Sridhar P; Deshpande A; O'Hara CJ; Yamada E; Godfrey TE; Fernando HC; Litle VR
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):714-727. PubMed ID: 28495058
[TBL] [Abstract][Full Text] [Related]
35. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
Niwa Y; Yamada S; Sonohara F; Kurimoto K; Hayashi M; Tashiro M; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
J Transl Med; 2019 Jan; 17(1):1. PubMed ID: 30602370
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients.
Fukuda N; Yunokawa M; Fujiwara Y; Wang X; Ohmoto A; Hayashi N; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1322. PubMed ID: 33295110
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
Mohamed A; Twardy B; Zordok MA; Ashraf K; Alkhoder A; Schrapp K; Steuer C; Chen Z; Pakkala S; Pillai R; Trad Wadsworth J; Higgins K; Beitler JJ; Ramalingam SS; Owonikoko TK; Khuri FR; Shin DM; Behera M; Saba NF
Head Neck; 2019 May; 41(5):1490-1498. PubMed ID: 30835900
[TBL] [Abstract][Full Text] [Related]
38. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C
Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145
[TBL] [Abstract][Full Text] [Related]
39. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
[TBL] [Abstract][Full Text] [Related]
40. Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.
McKibbin T; Cheng LL; Kim S; Steuer CE; Owonikoko TK; Khuri FR; Shin DM; Saba NF
Support Care Cancer; 2016 Apr; 24(4):1789-93. PubMed ID: 26446698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]